Suchergebnisse - "Tabernero, Josep"

PubPharm (820)

1

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Steeghs, N. | Gomez-Roca, C. | Rohrberg, K. | +16

2

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Peters, S. | Angevin, E. | Alonso-Gordoa, T. | +22

3

Targeting KRAS G12C Mutation in Colorectal Cancer, A Review : New Arrows in the Quiver

enthalten in: International journal of molecular sciences | 2024

von Ros, J. | Vaghi, C. | Baraibar, I. | +7

4

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer : phase 2 results from the CheckMate 9X8 randomized clinical trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Lenz, H. | Parikh, A. | Spigel, D. | +17

5

SEAMARK : phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC

enthalten in: Future oncology (London, England) | 2024

von Elez, E. | Kopetz, S. | Tabernero, J. | +8

6

Cetuximab every 2 weeks versus standard weekly dosing administration schedule

enthalten in: Future oncology (London, England) | 2024

von Bokemeyer, C. | Ciardiello, F. | Dubreuil, O. | +9

7

Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Brahmer, J. | Long, G. | Hamid, O. | +25

8

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585) : an interim analysis of the multicentre, double-blind, randomised phase 3 study

enthalten in: The Lancet. Oncology | 2024

von Shitara, K. | Rha, S. | Wyrwicz, L. | +22

9

Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms : A non-randomised evaluation

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Cohen, R. | Raeisi, M. | Chibaudel, B. | +14

10

Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer

enthalten in: Cancers | 2024

von Saoudi González, N. | Ros, J. | Baraibar, I. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[82]